April 27, 2011
From Reuters – April 28, 2011 – by Silke Koltrowitz
ZURICH, April 28 (Reuters) – Swiss dental implant maker
Nobel Biocare (NOBN.VX) said it expected to return to mid
single-digit growth, in line with the market, by mid-year, when
posting a weaker-than-expected first-quarter net profit.
Image by fe_cavallo via Flickr
Nobel Biocare, knocked off top spot in the dental implant
market by Swiss rival Straumann (STMN.S) last year, said on
Thursday net profit fell two thirds to 12.9 million euros ($18.9
The group booked a one-off currency gain of 30.1 million
euros in the 2010 period.